Utility of bevacizumab in chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia

被引：0
|
作者：
Gutierrez-Macias, A. [1 ,2 ]
Barroso-Benayos, I. [1 ]
Burzako-Sanchez, A. [1 ]
机构：
[1] Hosp Univ Basurto, Dept Med Interna, Bilbao, Spain
[2] Hosp Univ Basurto, Serv Med Interna, Ave Montevideo 18, Bilbao 48013, Bizkaia, Spain
来源：
REVISTA DE GASTROENTEROLOGIA DE MEXICO | 2023年 / 88卷 / 04期
关键词：
D O I：
10.1016/j.rgmx.2023.04.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：433 / 434
页数：2
相关论文
共 50 条
  • [1] Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
    Ou, George
    Galorport, Cherry
    Enns, Robert
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 8 (12): : 792 - 795
  • [2] Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia With Bevacizumab
    Masood, Muaaz
    Coles, Michael J.
    Asfari, Maysara
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1174 - S1174
  • [3] Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab
    Masood, Muaaz
    Coles, Michael
    Sifuentes, Humberto
    CASE REPORTS IN GASTROINTESTINAL MEDICINE, 2021, 2021
  • [4] Systemic Bevacizumab for the Treatment of Chronic Bleeding in Hereditary Hemorrhagic Telangiectasia
    Al-Samkari, Hanny
    Kritharis, Athena
    Rodriguez-Lopez, Josanna
    Kuter, David J.
    BLOOD, 2018, 132
  • [5] GASTROINTESTINAL BLEEDING IN HEREDITARY HEMORRHAGIC TELANGIECTASIA
    WILLIAMS, GA
    BRICK, IB
    ARCHIVES OF INTERNAL MEDICINE, 1955, 95 (01) : 41 - 51
  • [6] Bevacizumab as Rescue Treatment for Severe Recurrent Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia
    Lupu, Alexandru
    Stefanescu, Carmen
    Treton, Xavier
    Attar, Alain
    Corcos, Olivier
    Bouhnik, Yoram
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (03) : 256 - 257
  • [7] Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia
    Kjeldsen, AD
    Kjeldsen, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (02): : 415 - 418
  • [8] Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia-Related Epistaxis and Gastrointestinal Bleeding
    Iyer, Vivek N.
    Apala, Dinesh R.
    Pannu, Bibek S.
    Kotecha, Aditya
    Brinjikji, Waleed
    Leise, Michael D.
    Kamath, Patrick S.
    Misra, Sanjay
    Begna, Kebede H.
    Cartin-Ceba, Rodrigo
    DuBrock, Hilary M.
    Krowka, Michael J.
    O'Brien, Erin K.
    Pruthi, Rajiv K.
    Schroeder, Darrell R.
    Swanson, Karen L.
    MAYO CLINIC PROCEEDINGS, 2018, 93 (02) : 155 - 166
  • [9] An international survey to assess use of systemic bevacizumab for chronic bleeding in hereditary hemorrhagic telangiectasia
    Al-Samkari, H.
    Olitsky, S.
    Clancy, M.
    Iyer, V
    ANGIOGENESIS, 2019, 22 (04) : 624 - 625
  • [10] Successful management of chronic gastrointestinal hemorrhage using bevacizumab in the setting of hereditary hemorrhagic telangiectasia
    Sehl, Mary E.
    Gruber, Theresa M.
    McWilliams, Justin P.
    Marder, Victor J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (06) : 561 - 563
12345